STROKE REVASCULARIZATION DEVICE MARKET

INTRODUCTION

 Revascularization device is a neurovascular self-expanding, retrievable device that resembles a stent and is used to reestablish blood flow in patients who have suffered an ischemic stroke due to a major intracranial artery obstruction.

STROKE REVASCULARIZATION DEVICE MARKET SIZE AND FORECAST

The global stroke revascularization  device market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

STROKE REVASCULARIZATION DEVICE MARKET NEW PRODUCT LAUNCH

The Solitaire X Revascularization Device has been made available, and Medtronic plc has announced its first patient trials for the treatment of acute ischemic stroke. Doctors have been able to help patients with stroke have a higher chance of recovering because of the industry-leading Solitaire Revascularization Device.

The fourth generation of the Solitaire family of revascularization devices, Solitaire X, keeps the technical features that have made them very successful and clinically validated while incorporating an optimized distribution method for increased efficiency.

 Additionally, Medtronic unveils the Phenom 21 Catheter, a microcatheter with a length of 160 cm that can deliver all sizes of Solitaire X.Patients who have experienced an acute ischemic stroke with a major artery occlusion can regain blood flow by using the Solitaire X device, which mechanically eliminates blood clots from blocked brain vessels.

Solitaire X offers a reduced clot crossing profile and seamless distribution to occlusions in distal arteries as small as 2.0 mm when used in conjunction with Phenom 21. With this suitable system, Medtronic is even more dedicated to the fight against stroke

The Tigertriever Revascularization Device (RD), made by Rapid Medical Ltd., a subsidiary of MicroPort NeuroTech Co., Ltd.. Tigertriever is a totally retrievable medical gadget created to help patients with acute ischemic strokes regain blood flow. The mesh's outer diameter is regulated by a handle, unlike any previous commercial device.

Furthermore, Tigertriever is the only commercially available product that makes use of a unique 3D braided technique to build a mesh with a large pore size for optimal clot penetration. Tigertriever is made of an expandable wire shaft attached on a collapsible, totally retrievable,fine wire structure. A microcatheter is used to deliver the device intracranially.

A suite of three devices called CERENOVUS Stroke Solutions, part of Johnson & Johnson Medical Devices Companies, has been introduced to help doctors perform clot removal treatments. With compatibility in mind, CERENOVUS Stroke Solutions were created to aid medical professionals in performing mechanical thrombectomy treatments.

The range of technologies consists of: The newest generation stent retriever, the EMBOTRAP III Revascularization Device, is made to engage a variety of clot types, boost procedural confidence, and offer more specialised alternatives to accomplish the First Pass Effect (FPE)

The latest component of Penumbra, Inc.'s extensive Penumbra System, the RED 62 Reperfusion Catheter, has received approval from the U.S. Food and Drug Administration and is now commercially available. Penumbra, Inc. is a worldwide healthcare company with a focus on cutting-edge therapeutics.

Together with Penumbra ENGINE, RED 62 is made to manoeuvre through difficult distal artery anatomy and deliver forceful aspiration for the removal of blood clots in acute ischemic stroke patients with big vessel occlusions.

It is designed to help revascularize patients who have experienced an acute ischemic stroke due to intracranial major vessel occlusions. Reperfusion Catheters, 3D Revascularization Device, Penumbra ENGINE aspiration source, and other accessories are included with the Penumbra System.

STROKE REVASCULARIZATION DEVICE MARKET COMPANY PROFILES

• Covidien
• Phoenix
• Andratec
• Penumbra, Inc., 
•  Medtronic Plc.,
• Stryker,

THIS STROKE REVASCULARIZATION DEVICE MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

1. What is the average cost perglobal stroke revascularization  device marketright now and how will it change in the next 5-6 years?
2. Average cost to set up aglobal stroke revascularization  device marketin the US, Europe and China?
3. How manyglobal stroke revascularization  device marketsare manufactured per annum globally? Who are the sub-component suppliers in different regions?
4. What is happening in the overall public, globally?
5. Cost breakup of aglobal stroke revascularization  device marketand key vendor selection criteria
6. Where is theglobal stroke revascularization  device market manufactured? What is the average margin per equipment?
7. Market share ofglobal stroke revascularization  device marketmanufacturers and their upcoming products
8. The most important plannedglobal stroke revascularization  device marketin next 2 years
9. Details on network of majorglobal stroke revascularization  device marketand pricing plans
10. Cost advantage for OEMs who manufactureglobal stroke revascularization  device marketin-house
11. 5 key predictions for next 5 years inglobal stroke revascularization  device market
12. Average B-2-Bglobal stroke revascularization  device marketprice in all segments
13. Latest trends inglobal stroke revascularization  device market, by every market segment
14. The market size (both volume and value) ofglobal stroke revascularization  device marketin 2024-2030 and every year in between?
15. Global production breakup ofglobal stroke revascularization  device market, by suppliers and their OEM relationship